Startup Of the Week: IntelVasc

In this edition, we present you IntelVasc is transforming cardiovascular care with its minimally invasive biosensor that enables real-time blood flow monitoring. By providing proactive detection of vascular risks, the company helps prevent strokes, heart attacks, and amputations. IntelVasc’s remote monitoring platform empowers both patients and clinicians for smarter, earlier interventions.

Tell us about your company.

Andrew: IntelVasc is a medtech startup committed to shifting surgery from reactive to proactive care. We are developing the world’s first AI-powered remote monitoring system for peripheral artery disease (PAD) which affects over 200 million people globally. Our device, the Arterion System, enables minimally invasive, real-time vascular health tracking, allowing for early complication detection and better patient management.

What made you become an entrepreneur?

Andrew: I started my career in the medical device industry, working for large corporations. Over time, I noticed a critical unmet need in vascular health monitoring, where patients often go undiagnosed until it’s too late. After the tragic loss of my best friend to a stroke, I decided to build a team of experts in ultrasound engineering and vascular surgery to create a solution that could transform patient care.

What is the most challenging part of running your own startup?

Andrew: The biggest challenge is articulating our vision in a way that is both financially compelling and inspiring to stakeholders while fostering a strong internal culture in a rapidly evolving environment. Navigating daily startup hurdles demands continuous adaptability.

What is the biggest challenge you have faced when looking for funding?

Andrew: The biggest challenge has been finding the right investors—those who understand our hyper-regulated space and are not only focused on returns but also share our long-term vision of switching to proactive medicine for the benefit of humankind.

What is the most rewarding aspect of entrepreneurship?

Andrew: The most rewarding part is seeing our vision turn into reality. Every time a physician tells us that our solution could change how PAD is managed, it reinforces why we started IntelVasc.  Another rewarding aspect is building a team of passionate experts who believe in the mission. Seeing how we’ve grown from an idea into a company making real progress is an incredible feeling. 

Learn more about the company: https://intelvasc.com